Skip to main navigation

menu

Aclaris - Corp Menu

About Us »
« Back
Research »
« Back
Partnerships
Products
Careers
Citizenship »
« Back
Insights
Investors »
« Back

Aclaris - Extras Menu

Media resources
Contact us

Aclaris - Corp Menu

About Us »
« Back
Research »
« Back
Partnerships
Products
Careers
Citizenship »
« Back
Insights
Investors »
« Back

Aclaris - Investor Relations

Investor Overview
Stock Information
Press Releases
Events
SEC Filings
Corporate Governance
Investor Presentations
Investor FAQs
Email Alerts

Investor Contact

For investor related questions, please email

investors@aclaristx.com

Investor Overview

Stock quote

VOLUME:

View stock performance »

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Investor Overview

Press Releases

December 15, 2020

Aclaris Therapeutics Announces Formation of New Scientific Advisory Board

November 16, 2020

Aclaris Therapeutics to Participate in the Evercore ISI 3rd Annual HealthCONx Conference

November 4, 2020

Aclaris Therapeutics Reports Third Quarter 2020 Financial Results and Provides a Corporate Update

Events

Dec 2, 2020
7:30 AM EST

Aclaris Therapeutics, Inc. at Evercore ISI 3rd Annual HealthCONx Conference

Sep 17, 2020
10:40 AM EDT

Aclaris Therapeutics, Inc. at Cantor Virtual Global Healthcare Conference

Sep 15, 2020
12:30 PM EDT

Aclaris Therapeutics, Inc. at H.C. Wainwright & Co. 22nd Annual Global Investment Conference

Feature Presentation

Aclaris Therapeutics Company Overview - December 2020

Aclaris - Footer Menu

Terms of Use
Privacy Policy
Contact Us
Fraudulent Activity Notice

© 2021 Aclaris Therapeutics, Inc. All rights reserved. Unless otherwise noted, all trademarks referenced on this page are owned by Aclaris Therapeutics.